Evidence map›Paper›PMID 35033148›Full record

ArticleJournal of orthopaedic surgery and research2022

5-ALA-mediated fluorescence of musculoskeletal tumors in a chick chorio-allantoic membrane model: preclinical in vivo qualification analysis as a fluorescence-guided surgery agent in Orthopedic Oncology.

Wiebke K Guder, Wolfgang Hartmann, Clarissa Buhles, Maike Burdack, Maike Busch, Nicole Dünker, Jendrik Hardes, Uta Dirksen, Sebastian Bauer, Arne Streitbürger

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07038278 (5-AminoLevulinic Acid Aided Resection Margins in Sarcoma), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07038278 early_phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

5-AminoLevulinic Acid Aided Resection Margins in Sarcoma (5-ALARMS)

TypeinterventionalSponsorUniversity of Colorado, DenverRan2026 to 2028Enrolled20ConditionsSoft Tissue Sarcoma (STS)Arms5-ALA
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. AnOncology research · 2026
    Article
  4. Review
  5. Article
  6. Implementation of a CAM Assay Using Fibrosarcoma Spheroids.International journal of molecular sciences · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Wiebke K GuderDepartment of Orthopedic Oncology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany. wiebke.guder@uk-essen.de.ORCID http://orcid.org/0000-0001-9367-7130
Wolfgang HartmannDivision of Translational Pathology, Gerhard-Domagk-Institute of Pathology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Building D17, 48149, Muenster, Germany.
Clarissa BuhlesDepartment of Orthopedic Oncology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Maike BurdackDepartment of Orthopedic Oncology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Maike BuschDepartment of Neuroanatomy, Institute for Anatomy II, University of Duisburg Essen, University Medicine Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Nicole DünkerDepartment of Neuroanatomy, Institute for Anatomy II, University of Duisburg Essen, University Medicine Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Jendrik HardesDepartment of Orthopedic Oncology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Uta DirksenDepartment of Pediatric Hematology and Oncology (III), University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Sebastian BauerSarcoma Center, West German Cancer Center, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Arne StreitbürgerDepartment of Orthopedic Oncology, University Hospital Essen, Hufelandstrasse 55, 45147, Essen, Germany.
Essen University Hospital · DEUniversity of Duisburg-Essen · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFluorescence-guided surgery (FGS) with 5-aminolevulinic acid (5-ALA) and other contrast agents has shown its efficacy in improving resection margins, local recurrence and survival rates in several medical disciplines. It is the objective of this study to analyze the engraftment rate of musculoskeletal tumor specimens on the chick chorio-allantoic membrane (CAM), the rate of tumor fluorescence (PDD), and the effects of photodynamic therapy (PDT) after exposure of tumors to 5-ALA in an in vivo environment.

methodsA total of 486 CAMs were inoculated with macroscopic tumor grafts (n = 26; n = 478 eggs) and primary cell culture suspensions (n = 2; n = 8 eggs) from 26 patients on day 10 of egg development. On day 16, 2 mg/200 µl 5-ALA were topically applied per egg. After 4 h of incubation, Protoporphyrin IX was excited using blue light (420 ± 10 nm). Tumor fluorescence (PDD) was photo-documented. A subgroup of specimens was additionally exposed to red light (635 nm ± 10 nm; PDT). After the termination of the experiment, CAM-grown tumors were histopathologically analyzed.

resultsBenign and borderline tumors (chondroblastoma, giant cell tumor of bone and atypical chondrogenic tumor) presented with high rates of detectable fluorescence. Comparable results were found for chondrosarcoma, osteosarcoma and Ewing's sarcoma among bone and dedifferentiated liposarcoma, myxofibrosarcoma and undifferentiated pleomorphic sarcoma among soft tissue sarcomas. Overall, tumor fluorescence was negative for 20.2%, single-positive (+) for 46.9% and double-positive (++) for 32.9% of macroscopic xenografts, and negative in 20% and (+) in 80% of primary cell culture tumors. Macroscopic tumor xenografts (n = 478) were identified as viable in 14.8%, partially viable in 2.9% and partially to completely regressive in 45.2%. All (n = 8) tumors grown from primary cell culture were viable. After PDT, tumor samples were found viable in 5.5%, partially viable in 5.5% and partially to completely regressive in 68%. Egg survival increased with decreasing PDT doses.

conclusionsThe CAM model proves to be a suitable in vivo model for the investigation of short-term observation questions in musculoskeletal tumors. The findings of this study warrant further investigation of PDT effects on musculoskeletal tumors and a possible incorporation of 5-ALA FGS in clinical Orthopedic Oncology care.

Indexed as

Aminolevulinic AcidFluorescenceOrthopedic ProceduresSurgical OncologyAllantoisAnimalsChick EmbryoContrast MediaFluorescent DyesPhotochemotherapySensitivity and SpecificitySurgery, Computer-AssistedAminolevulinic AcidContrast MediaFluorescent Dyes5-Aminolevulinic acidChick chorio-allantoic membrane modelMusculoskeletal tumorPhotodynamic detectionSarcomaTumor fluorescence

Identifiers

PMID35033148
PMCPMC8761327
OpenAlexW4205248358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.